Biotech Risks TACOMA (KPLU) - Stock in the Pfizer Pharmaceutical Company plummeted this week after the company halted testing of a new cholesterol drug. Financial commentator Gerg Heberlein says it's a good example of how risky biotech stocks can be. He spoke with KPLU's Dave Meyer. 3:30 © Copyright 2009, KPLU